For the millions managing Type 2 diabetes or navigating depression, the hardest part isn't knowing what to do. It's doing it, day after day, when motivation is low and life is loud. HumLife360, a New York-based digital health startup founded in 2017, is betting that the right nudge, delivered at the right moment, can make that daily execution just a little bit easier. Its platform, described by founder Harsh Mulik as a "Behavioral Execution Infrastructure," aims to learn an individual's unique behavior markers and deliver personalized, context-aware prompts to support health goals [Perplexity Sonar Pro Brief, Unknown].
It's a quiet, patient-centric approach in a digital health market often fixated on clinical devices or intensive coaching. The company's public focus is twofold: simplifying and reducing the cost of managing Type 2 diabetes through what it calls "Smart Nudges," and extending similar support to mental health conditions like depression, social anxiety, and burnout [Perplexity Sonar Pro Brief, Unknown]. The wedge is not a new drug or a diagnostic tool, but a software layer designed to make existing care plans stick.
A Wedge in Daily Habit Execution
HumLife360's core proposition is that generic advice fails because it ignores individual context. The platform's engine, which the company says is driven by behavioral science, AI, and natural language processing, is intended to identify personal motivators and resistors [Perplexity Sonar Pro Brief, Unknown]. In practice, this might mean a nudge about a walk timed just after a user typically finishes lunch, or a supportive message framed in a way that resonates with their specific anxiety triggers.
The company positions this as a move beyond one-size-fits-all digital coaching. Its marketing emphasizes affordability and lifelong support, aiming to keep patients engaged with what it claims is a minimal daily time commitment [Perplexity Sonar Pro Brief, Unknown]. For a condition like Type 2 diabetes, where consistent management of diet, exercise, and medication is critical but notoriously difficult, the potential impact of sustained, personalized engagement is significant. The same logic applies to mental health, where daily routines and cognitive patterns are central to management.
The Team and Its Advisor
The public face of the company is Harsh Mulik, its founder and CEO. His LinkedIn profile frames the mission as "Turning Human Nudging Into a Scalable Behavior-Change Engine" [LinkedIn, Unknown]. The backgrounds of co-founders Aaron Turner and Jeffrey Foy are less clear in available sources. A notable addition to the team's orbit is Stephanie Leung, PhD, a psychologist who has joined as an advisor on mental health solutions [LinkedIn, 2026]. Leung's specialty is particularly relevant; her prior work at the Fleischer Institute for Diabetes & Metabolism focused on the psychosocial problems, like anxiety and depression, that complicate diabetes care [EinsteinMed, Unknown]. This advisor role suggests a deliberate effort to ground the mental health expansion in clinical psychology.
| Role | Name | Key Detail |
|---|---|---|
| Founder & CEO | Harsh Mulik | Describes HumLife360 as "Behavioral Execution Infrastructure" [LinkedIn, Unknown]. |
| Co-Founder | Aaron Turner | Role at HumLife360 not confirmed by secondary sources [Perplexity Sonar Pro Brief, 2026]. |
| Co-Founder | Jeffrey Foy | Role at HumLife360 not confirmed by secondary sources [Perplexity Sonar Pro Brief, 2026]. |
| Advisor, Mental Health Solutions | Stephanie Leung, PhD | Psychologist specializing in mental health and diabetes care [LinkedIn, 2026]. |
The Early-Stage Reality Check
HumLife360 operates in a pre-seed stage, and the public record reflects the challenges typical of that phase. The company is small, with headcount estimates ranging from 2-10 employees [LinkedIn, 2026]. While it claims its technology involves "patent pending behavior nudges," this is not verifiable via public USPTO records [Perplexity Sonar Pro Brief, 2026]. More critically for a health intervention, there is no accessible evidence of FDA clearance, published clinical outcomes, or formal partnerships with health systems or payers [Perplexity Sonar Pro Brief, 2026].
The competitive landscape includes established digital health players like Lark and Klinic, which have built substantial user bases in chronic condition management [Crunchbase, Unknown]. HumLife360's answer appears to be a deeper specialization in the behavioral science layer, rather than a broader telehealth or coaching service. Its success will hinge on proving that this specialized focus creates measurably better habit formation and health outcomes than more generic apps. Without published data or regulatory milestones, that claim remains an ambition.
The Path to Proof
The next twelve months for HumLife360 will be about moving from concept to validation. The key milestones to watch are not just user growth, but evidence generation. For a company targeting regulated health conditions, progress often looks like:
- A pilot publication. Partnering with a clinical research group to run a small, controlled study on the platform's effect on HbA1c levels or depression symptom scores.
- Regulatory clarity. Determining if the platform operates as a wellness product or seeks FDA clearance as a digital therapeutic, a much more rigorous path.
- A clear business model. The company targets both diabetes and mental health, which have different reimbursement pathways. Clarifying whether the model is direct-to-consumer, B2B2C through employers, or integrated with provider networks will be essential.
The company's advisory link to Stephanie Leung, PhD, provides a credible bridge to the clinical world. Converting that into a formal research collaboration would be a logical and impactful next step.
For patients with Type 2 diabetes and comorbid depression or anxiety, the standard of care today is often fragmented. They may see an endocrinologist for blood sugar management and a separate therapist or psychiatrist for mental health, with little integration between the two. Daily self-management falls entirely on the patient, supported by periodic appointments and, sometimes, a generic wellness app. The burden of coordinating this care and maintaining daily discipline is high, and lapses are common. HumLife360 is attempting to build a persistent, adaptive layer of support that sits in that gap, aiming to be the gentle, consistent partner that the current system lacks. Whether its AI-driven nudges can reliably replicate the nuanced guidance of a human coach, and prove it in a clinical setting, is the bet its team must now validate.
Sources
- [Perplexity Sonar Pro Brief, Unknown] HumLife360 company brief | https://humlife360.com/
- [LinkedIn, 2026] Stephanie Leung, PhD advisor profile | https://www.linkedin.com/in/stephanie-leung-phd-538b378/
- [EinsteinMed, Unknown] Profile of Stephanie Leung, PhD at Fleischer Institute | https://einsteinmed.edu
- [Crunchbase, Unknown] Competitor profiles for Lark and Klinic | https://www.crunchbase.com
- [LinkedIn, Unknown] Harsh Mulik profile | https://www.linkedin.com/in/harshmulik/
- [PitchBook, 2025] HumLife360 company profile | https://pitchbook.com/profiles/company/489035-89